Systemic therapy for advanced hepatocellular carcinoma: an update.
about
miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma cell growth and metastasis.Review of Regorafenib for the Treatment of Hepatocellular CarcinomaIncidence and risk of regorafenib-induced hepatotoxicity.Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review.Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.Multi-omics integration reveals the landscape of pro-metastasis metabolism in hepatocellular carcinoma.Venous invasion by hepatic tumors: imaging appearance and implications for management.Case-report: Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver: Surgical therapy.A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor.Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma.Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administrationResolvin D1 inhibits the proliferation of lipopolysaccharide-treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway
P2860
Q41190055-96E1CF47-DE39-4406-B92F-8CAB4ABA81B0Q41531315-3A7A808C-3D65-4FAF-894C-C7CBFC6928E4Q45800216-450CFB4C-7AAC-47B5-9206-62C151EF6DBFQ47121307-6E44FEEA-E0BE-4FE8-A4B2-DF6FB50DA397Q47138737-34F469D2-6A0C-4111-BD71-250DA41C3217Q49209465-E1F03DBC-97F7-471C-8808-EBC02DA77DDCQ49682532-0741C87C-2076-4A11-9C54-678317DD58BFQ50002836-3DDB861E-12A0-4E0B-8C1E-EFAAE58518FFQ55282213-8D51E384-ED98-4F83-BDC0-318765D640E8Q55312817-BBA40B9C-479D-4744-9469-1590ED1E16B1Q55497559-0E22FF06-824C-4DC6-8FB4-D27031954F94Q58547786-DC9423FA-CC38-4CD2-87EA-CE5517282877Q58710795-F9C4E590-6468-464F-89A2-4D4DAEA81C3B
P2860
Systemic therapy for advanced hepatocellular carcinoma: an update.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Systemic therapy for advanced hepatocellular carcinoma: an update.
@ast
Systemic therapy for advanced hepatocellular carcinoma: an update.
@en
type
label
Systemic therapy for advanced hepatocellular carcinoma: an update.
@ast
Systemic therapy for advanced hepatocellular carcinoma: an update.
@en
prefLabel
Systemic therapy for advanced hepatocellular carcinoma: an update.
@ast
Systemic therapy for advanced hepatocellular carcinoma: an update.
@en
P2093
P2860
P356
P1476
Systemic therapy for advanced hepatocellular carcinoma: an update.
@en
P2093
Aiwu Ruth He
Jasmin Radhika Desai
Petra Alexandra Prins
Sebastian Ochoa
P2860
P304
P356
10.21037/JGO.2017.02.01
P577
2017-04-01T00:00:00Z